Physician profile
Evan C Lipsitz
NPI 1255413407
$17,159.71
in general payments reported to CMS, 2019-2025
43 companies · $1,584 in 2025
The $1,584 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,945 · 2020: $553 · 2021: $2,078 · 2022: $2,507 · 2023: $3,489 · 2024: $5,004 · 2025: $1,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,456 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,480 · Travel and Lodging: $1,198 · Consulting Fee: $800 · Education: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,456.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,480.00 |
| Travel and Lodging | $1,198.49 |
| Consulting Fee | $800.00 |
| Education | $141.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $5,222.40 | 2019-2025 | Zenith Spiral-Z, Zilver Ptx, Cook |
| Boston Scientific Corporation | $2,676.38 | 2019-2025 | Angiojet Ultra 5000a, Eluvia, General - Vascular Intervention |
| Cook Incorporated | $2,480.00 | 2024 | Zenith Spiral-Z |
| Bolton Medical INC | $1,631.84 | 2019-2023 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $656.21 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $626.63 | 2021-2025 | Endurant Iis, Ellipsys Vascular Access System |
| Medline Industries LP | $494.76 | 2019-2022 | |
| Argon Medical Devices, INC. | $371.74 | 2021-2023 | Cleaner |
| Smith+Nephew, INC. | $343.22 | 2019-2024 | Collagenase Santyl |
| Terumo Medical Corporation | $327.82 | 2019-2024 | Metacross Otw, Navicross |
| Stryker Corporation | $221.98 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Silk Road Medical, INC. | $178.90 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Balt USA, LLC | $172.63 | 2021-2023 | Prestige Coil System |
| Shockwave Medical, INC | $165.40 | 2021-2025 | |
| Inari Medical, INC. | $164.49 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $158.10 | 2023 | Lutonix Drug Coated Balloon |
| Janssen Pharmaceuticals, INC | $155.77 | 2019-2022 | |
| Integra Lifesciences Corporation | $152.16 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Penumbra, INC. | $115.57 | 2021-2023 | Indigo System |
| Inspiremd LTD | $85.01 | 2025 | Cguard Prime Carotid Stent System |
| Getinge USA Sales, LLC | $76.79 | 2021-2025 | Flixene |
| Artivion, INC. | $70.50 | 2024 | Vascular, Photofix Decellularized Bovine Pericardium, Bioglue Surgical Adhesive |
| Abbott Laboratories | $69.95 | 2025 | Xact |
| Solventum Corporation | $62.36 | 2025 | Activ.A.C., 3m Coban |
| Tactile Systems Technology INC | $59.38 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Lemaitre Vascular, INC. | $54.37 | 2019 | |
| Kerecis Limited | $51.10 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $50.02 | 2022-2023 | |
| Advanced Oxygen Therapy INC. | $43.05 | 2021-2025 | Topical Oxygen Chamber For Extremities |
| Angiodynamics, INC. | $42.76 | 2024 | Auryon Laser System 100-120 Vac |
| Endologix LLC | $27.84 | 2025 | Endocross Device, Torus Stent Graft System |
| Humacyte Global, INC. | $27.30 | 2025 | Symvess |
| Organogenesis INC. | $26.33 | 2023 | Puraply |
| Cardiva Medical, INC. | $23.79 | 2022 | |
| Hydrofera LLC | $16.61 | 2024 | Hydrofera Blue |
| Cumberland Pharmaceuticals, INC. | $15.90 | 2024 | Caldolor |
| Teleflex LLC | $14.58 | 2023 | Manta |
| Cardinal Health 200 LLC | $13.57 | 2019 | |
| Cardiovascular Systems INC. | $12.50 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,055.21 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$605,917.47 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Lipsitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.